TRPC6 and breast carcinoma: PEMF exposure attenuates the proliferative and migratory capacities of breast cancer cells in positive correlation to TRPC1 channel expression (Figures 5 and 7), aligning with evidence that catalytic activation of TRPC6, similarly implicated with proliferation and inflammatory responses in breast cancer, attenuates MDA-MB-231 breast cancer cell viability and migratory capacity (51).